A.F. Hottinger

Discipline

Psychologie (4) Histoire, Philosophie et Sociologie des sciences (3)

Type de document

Articles (25) Recensions (10)

Co-auteur

Date

Source

Mot-clé

Treatment (22) Patients (18) Patients (18) Brain (15) cerveau (15) Human beings (14) thérapie (11) Therapeutics (11) survie (10) Tumors (10) Survival (10) Management (10) gestion (9) Cancer (9) Management (9) analyse (8) adulte (8) cancer (8) Chemotherapy (8) Cancer (8) Chemotherapy (8) Analysis (8) Tumors (8) adulte (8) Months (7) maladie (6) procès (6) Gliomas (6) Antineoplastic agents (6) Adulthood (6)

Documents écrit par A.F. Hottinger (25) | parle de A.F. Hottinger (0)

The local microenvironment drives activation of neutrophils in human brain tumors.
R.R. Maas et al. (12 oct. 2023)
Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation.
V. Wischnewski et al.
Safety and anti-tumor activity of lisavanbulin administered as 48-hour infusion in patients with ovarian cancer or recurrent glioblastoma: a phase 2a study.
M. Joerger et al.
Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumors.
Á.F. Álvarez-Prado et al. (17 janv. 2023)
Prise en charge des métastases cérébrales en 2022 [Management of brain metastases in 2022]
L. Schiappacasse et al. (18 mai 2022)
Metabolic and transcriptomic profiles of glioblastoma invasion revealed by comparisons between patients and corresponding orthotopic xenografts in mice.
C. Cudalbu et al. (4 août 2021)
Immunotherapy in Glioblastoma: A Clinical Perspective.
N. Desbaillets et al. (24 juil. 2021)
Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033.
M. Klein et al. (5 mai 2021)
Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial.
Z. Ram et al. (2021)
Urgent Considerations for the Neuro-oncologic Treatment of Patients with Gliomas During the COVID-19 Pandemic.
N.A. Mohile et al. (22 juil. 2020)
A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults.
P. Roth et al. (1 juin 2020)
Effect of everolimus on multifocal micronodular pneumocyte hyperplasia in tuberous sclerosis complex.
C. Daccord et al. (2020)
Therapeutic Drug Monitoring of Newer Antiepileptic Drugs: A Randomized Trial for Dosage Adjustment.
I. Aícua-Rapún et al.
Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient.
V. Pillonel et al. (2 déc. 2019)
Chemotherapy and diffuse low-grade gliomas: a survey within the European Low-Grade Glioma Network.
A. Darlix et al.
Natalizumab may control immune checkpoint inhibitor-induced limbic encephalitis.
A.F. Hottinger et al.
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
R. Stupp et al. (19 déc. 2017)
Current management of low-grade gliomas.
A.F. Hottinger et al.
Tumor treating fields: a novel treatment modality and its use in brain tumors.
A.F. Hottinger et al.
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.
R. Stupp et al. (2015)
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma.
A.F. Hottinger et al. (2014)
Standards of care and novel approaches in the management of glioblastoma multiforme.
A.F. Hottinger et al. (2014)
Decision making and management of gliomas: practical considerations.
A.F. Hottinger et al. (2012)
Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers.
R. Stupp et al. (2008)
Complete and long-term rescue of lesioned adult motoneurons by lentiviral-mediated expression of glial cell line-derived neurotrophic factor in the facial nucleus.
A.F. Hottinger et al.